1. Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care

3. Program Goals

4. Hyperkalemia: Overview Episode or Long-Term Consequence?

5. Causes of Hyperkalemia

6. Hyperkalemia: The Continuum Clinical Presentation for In-Patient

7. Acute Treatment of Hyperkalemia: Effective, but Not a Long-Term Solution

8. The Emergency Department: Home for Acute Hyperkalemia

9. Hyperkalemia in the Hospital Setting

10. Hyperkalemia in the Critical Care Setting

11. Balancing RAAS Inhibitor Use and Potassium Level

12. Korean Study Evaluating Potassium Levels and Mortality in Dialysis Patients

13. Guidelines Recommendations Regarding RAAS Inhibitor Use Based on Serum Potassium Level

14. Methods to Lower Potassium Without Compromising Chronic Medical Therapy

15. Patiromer: Structure

16. AMETHYST-DN: Patiromer 52-Week Study

17. PEARL-HF: Patients With HF Receiving Standard Therapy and Spironolactone Treated With Patiromer

18. ZS-9: Structure

19. New Potassium Binders and Prevention of Hyperkalemia: Unanswered Questions and Clinical Implications

20. Comparison of SPS, Patiromer, and ZS-9

21. The Role of New Potassium-Binding Agents in Hypothetical Situations

22. Relationship Between Potassium Level and Patient Outcome

23. Managing Hyperkalemia Is a Team Effort

24. Transition of Care With Hyperkalemia: From Acute to Chronic Care

25. Key Takeaways

26. Abbreviations

27. Abbreviations (cont)